Propidium Iodide Solution

Pricing & Availability
Regulatory Status
RUO
Other Names
PI
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
421301 2 mL 44€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Propidium iodide (PI) is a fluorescent dye that binds to DNA. When excited by 488nm laser light, it can be detected with in the PE/Texas Red® channel with a bandpass filter 610/10. It is commonly used in evaluation of cell viability or DNA content in cell cycle analysis by flow cytometry.

Product Details
Technical Data Sheet (pdf)

Product Details

Formulation
Phosphate-buffered saline, pH 7.2, containing 0.09% sodium azide.
Concentration
0.5 mg/ml
Storage & Handling
The solution should be stored undiluted between 2°C and 8°C, and protect from light. Caution: This solution contains hazardous material; handle with care.
Application

FC - Quality tested

Recommended Usage

The suggested use of this solution for viability staining is 10 µl per million cells in 0.5 ml/test, and incubate for 15 minutes at 4 °C before analysis. For Cell Cycle analysis, please see our Propidium Iodide Cell Cycle Staining Protocol. Caution: This solution is toxigenic and mutagenic; handle with care.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Propidium Iodide Solution can be used in evaluation of apoptosis, cell viability and cell cycle analysis by flow cytometry.

Application References
  1. Vermes I, et al.1995. J. Immunol. Methods 184:39.
  2. Darzynkiewicz Z, et al. 1992. Cytometry 13(8):795.
  3. Douglas RS, et al. 1995. J. Immunol. Methods 188:219.
  4. Sakimoto I, et al. 2006. Cancer Research 66:2287.PubMed
  5. Liu H, et al. 2012. Int J Biochem Cell Biol. 45:408. PubMed
  6. Juel HB, et al. 2013. PLoS One. 8:64619. PubMed
  7. Ren Q, et al. 2013. PLoS One. 8:74732. PubMed
  8. Zhao W, et al. 2013. Clin Immunol. 149:119. PubMed
  9. Beggs KM, et al. 2014. Toxicol Sci. 137:91. PubMed
  10. Ewald SE, et al. 2014. Infect Immun. 82:460. PubMed
  11. Tsou WI, et al. 2014. J Biol Chem. 289:25750. PubMed
  12. Kong S, et al. 2014. J Immunol. 193:5515. PubMed
Product Citations
  1. Li W, et al. 2019. Aging (Albany NY). 0.99375. PubMed
  2. Liu H, et al. 2012. Int J Biochem Cell Biol. 45:408. PubMed
  3. Ewald S, et al. 2014. Infect Immun . 82:460. PubMed
  4. Guo H, et al. 2016. Sci Rep. 6:37559. PubMed
  5. Smith A, et al. 2017. Sci Rep. 7:41872. PubMed
  6. Chan J, et al. 2017. Oncogene. 10.1038/onc.2017.319. PubMed
  7. Uroda T, et al. 2019. Mol Cell. 75:982. PubMed
  8. Lindqvist B, et al. 2022. PLoS Pathog. 18:e1010555. PubMed
  9. Neumann CKA, et al. 2020. Mol Metab. 34:136. PubMed
  10. Hamel Y, et al. 2021. Cell Rep Med. 2:100370. PubMed
  11. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  12. Leeth C, et al. 2021. Animals (Basel). 11:. PubMed
  13. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
  14. McNeal AS, et al. 2021. Elife. 10:. PubMed
  15. He Y, et al. 2020. Nat Commun. 11:1996. PubMed
  16. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  17. Yoshioka H, et al. 2021. Front Cell Dev Biol. 9:621045. PubMed
  18. Yang Y, et al. 2021. Metabolism. 123:154863. PubMed
  19. Coray M, et al. 2022. Int J Mol Sci. 23:. PubMed
  20. Ren Q, et al. 2013. PLoS One. 8:74732. PubMed
  21. Zeng H, et al. 2018. Cancer Cell. 34:56:00. PubMed
  22. Lei W, et al. 2020. Sci Rep. 10:7004. PubMed
  23. Wang Y, et al. 2019. Cell. 179:1144. PubMed
  24. Zhang M, et al. 2017. Oncol Lett. 3.069444444. PubMed
  25. Zhang W, et al. 2021. J Clin Invest. 131:. PubMed
  26. Ambrosi TH, et al. 2021. Elife. 10: . PubMed
  27. Schrier S, et al. 2016. Sci Rep. 6:34942. PubMed
  28. O'Neill K, et al. 2016. Genes Dev. 30: 973-988. PubMed
  29. Sapanidou V, et al. 2015. Theriogenology. . PubMed
  30. Kong S, et al. 2014. J Immunol. 193:5515. PubMed
  31. Chen C, et al. 2019. Cell Rep. 29:4200. PubMed
  32. Liu L, et al. 2019. Cell Prolif. :e12718. PubMed
  33. Zou PA, et al. 2021. Oncol Lett. 22:648. PubMed
  34. Masuda T, et al. 2022. iScience. 25:104781. PubMed
  35. Feng L, et al. 2016. J Cell Sci. 129: 2202 - 2212. PubMed
  36. Lange N, et al. 2016. PLoS One. 11: 0160843. PubMed
  37. Jordan PM, et al. 2020. Cell Rep. 33:108247. PubMed
  38. Liu Y, et al. 2017. Acta Biomater. 10.1016/j.actbio.2017.08.021. PubMed
  39. Reighard SD, et al. 2020. Cell Rep Med. :1. PubMed
  40. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  41. Xu B, et al. 2016. Leukemia. 10.1038/leu.2016.297. PubMed
  42. Yang M, et al. 2021. Med Sci Monit. 27:e930083. PubMed
  43. Domenis R, et al. 2017. PLoS One. 10.1371/journal.pone.0169932. PubMed
  44. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  45. Liu H, et al. 2020. Cell Death Dis. 0.767361111. PubMed
  46. Li L, et al. 2018. Oncol Lett. 4.184722222. PubMed
  47. Jung E, et al. 2017. J Neurosci. 37:6837. PubMed
  48. Basso-Ricci L, et al. 2017. Cytometry A. 10.1002/cyto.a.23148. PubMed
  49. Matsuda K, et al. 2021. Cell Rep Methods. 1:100122. PubMed
  50. Pang K, et al. 2022. Cell Death Dis. 13:169. PubMed
  51. Tang X, et al. 2021. Transl Cancer Res. 10:2120. PubMed
  52. Zhang X, et al. 2020. Eur J Med Chem. 112186:192. PubMed
  53. Mensen A, et al. 2015. Biol Blood Marrow Transplant. Available online 10 August 2015. PubMed
  54. Zhao W, et al. 2013. Clin Immunol. 149:119. PubMed
  55. Litzenburger UM, et al. 2017. Genome Biol. 18:15. PubMed
  56. Shanahan MT, et al. 2021. Am J Physiol Gastrointest Liver Physiol. 321:G668. PubMed
  57. Wang J, et al. 2022. J Clin Invest. :. PubMed
  58. Trudu M, et al. 2022. Front Oncol. 12:968208. PubMed
  59. Li Y, et al. 2016. Int J Lower Extrem Wounds. 10.1177/1534734616649485. PubMed
  60. Hu D, et al. 2020. Proc Natl Acad Sci U S A. 117:30639. PubMed
  61. Li Q, et al. 2020. Acta Biochim Biophys Sin (Shanghai). 52:1131. PubMed
  62. Moribe F, et al. 2021. PLoS One. 16:e0237554. PubMed
  63. Perl AL, et al. 2019. J Biol Chem. 294:17043. PubMed
  64. Diaz Osterman CJ, et al. 2019. Elife. 8:e47327. PubMed
  65. Hosokawa T, et al. 2017. J Immunol. 10.4049/jimmunol.1700157. PubMed
  66. El-Hafeez A, et al. 2017. Cytotechnology. 10.1007/s10616-017-0124-1. PubMed
  67. Xue G, et al. 2021. Nat Biomed Eng. 5:1306. PubMed
  68. Lasrado N, et al. 2022. iScience. 25:103865. PubMed
  69. L Chang, Y Li, D Kaplan 2016. Sci Rep. 6:36862. PubMed
  70. Tsou W, et al. 2014. J Biol Chem. 289:25750. PubMed
  71. Oubaha M, et al. 2016. Sci Transl Med. 8: 362ra144. PubMed
  72. Polk A, et al. 2016. Clin Cancer Res. 22(24):6118-6128. PubMed
  73. El-Hafeez A, et al. 2017. Cytotechnology. 10.1007/s10616-017-0116-1. PubMed
  74. Xie M, et al. 2017. BMC Cancer . 10.1186/s12885-017-3291-8. PubMed
  75. Pal P, et al. 2021. J Med Chem. 64:14230. PubMed
  76. Hedemann N, et al. 2021. Cancers (Basel). 13:. PubMed
  77. Xie B, et al. 2021. J Immunol. 206:1515. PubMed
  78. Harro CM, et al. 2020. J Clin Invest. . PubMed
  79. Imura Y, et al. 2020. JCI Insight. :5. PubMed
  80. Suzuki S, et al. 2021. STAR Protocols. 2(3):100683. PubMed
  81. Vickman R, et al. 2016. Mol Cancer Res. 14: 776 - 786. PubMed
  82. Huang K, et al. 2018. Biol Open. 7:bio029470. PubMed
  83. Wang H, et al. 2019. Nat Commun. 4.388194444. PubMed
  84. Matsubara T, et al. 2022. J Exp Med. 219:. PubMed
  85. M H, et al. 2016. Cell Transplant. 25: 811-27. PubMed
  86. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  87. Liu X, et al. 2019. Mol Cancer Ther. 18:706. PubMed
  88. Yang X, et al. 2017. J Control Release. 10.1016/j.jconrel.2017.07.014. PubMed
  89. Viereckl MJ, et al. 2022. Biomolecules. 12:. PubMed
  90. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  91. Hughes K, et al. 2017. Open Bio. 10.1098/rsob.160155. PubMed
  92. Resch U, et al. 2016. MBio. 7: e00207-16. PubMed
  93. Bao W, et al. 2016. Sci Rep. 6:22579. PubMed
  94. Bjørnstad R, et al. 2019. Mol Cancer Ther. 1.14375. PubMed
  95. Ghura H, et al. 2021. Neoplasia. 23:837. PubMed
  96. Beggs K, et al. 2014. Toxicol Sci. 137:91. PubMed
  97. Wang C, et al. 2017. Drug Deliv. 10.1080/10717544.2017.1293195. PubMed
  98. Nilsri N, et al. 2021. Sci Rep. 5255:11. PubMed
  99. He Y, et al. 2020. J Hematol Oncol. 0.607638889. PubMed
  100. Widodo N, et al. 2022. F1000Res. 11:169. PubMed
  101. Bensberg M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  102. Siddhartha V, et al. 2017. Artif Cells Nanomed Biotechnol . 10.1080/21691401.2017.1313267. PubMed
  103. Viseshakul N, et al. 2017. Parasitol Res. 10.1007/s00436-017-5589-5. PubMed
  104. Chmielewski M and Abken H 2017. Cell Rep.. 10.1016/j.celrep.2017.11.063. PubMed
  105. Sakimoto I, et al. 2006. Cancer Res. 66:2287. PubMed
  106. Goel S, et al. 2021. Nat Commun. 12:5325. PubMed
  107. Szeto C, et al. 2022. Nat Commun. 13:4951. PubMed
  108. Namas R, et al. 2016. Lupus Sci Med. 3: e000148. PubMed
  109. Chen Y, et al. 2016. J Biol Chem. 291: 13216 - 13228. PubMed
  110. Deng BB, et al. 2020. Cell Biol Int. 44:1890. PubMed
  111. Popa S, et al. 2020. Wellcome Open Res. 0.249305556. PubMed
  112. Vulin M, et al. 2022. Oncogene. :. PubMed
  113. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  114. Mahmoudi M, et al. 2016. Sci Rep. 6:26960. PubMed
  115. Juel H, et al. 2013. PLoS One. 8:64619. PubMed

Antigen Details

Biology Area
Cell Biology, Cell Cycle/DNA Replication, Neuroscience
Gene ID
NA

Related FAQs

Why is washing not recommended after the addition 7-AAD or PI addition when assessing viability?

These dyes bind in equilibrium with DNA. Therefore, external dye concentration must be maintained during analysis and the dye should not be washed out.

Go To Top Version: 2    Revision Date: 10/08/2015

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account